| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/17/2011 | US20110064657 Labeled inhibitors of prostate specific membrane antigen (psma), biological evaluation, and use as imaging agents |
| 03/17/2011 | US20110064613 Fluid sample testing system |
| 03/17/2011 | US20110062616 Test paper and porous membrane |
| 03/17/2011 | US20110062324 Mass spectrometer with bypass of a fragmentation device |
| 03/17/2011 | US20110061479 Method and apparatus for determining the nodosity of a wooden plank |
| 03/17/2011 | US20110061478 Method of making large area conformable shape structures for detector/sensor applications using glass drawing technique and postprocessing |
| 03/17/2011 | US20110061458 Methods Of Using An Electrochemical Biosensor |
| 03/17/2011 | US20110061447 Biological agent detector |
| 03/17/2011 | US20110061442 Vent and soil flux measurement system |
| 03/17/2011 | US20110061440 Device and method for metering materials into a carrier matrix |
| 03/17/2011 | US20110061439 Methods of calibrating a fluid analyzer for use in a wellbore |
| 03/17/2011 | DE112009000437T5 System und Verfahren zum Verbessern der Sequenzierungsgenauigkeit eines Polymers System and method for improving the accuracy of sequencing a polymer |
| 03/17/2011 | DE102009035014A1 Method for sensitive and continuous regulation of organic substances contained in water, involves radiation of radiation source at end in fiber |
| 03/17/2011 | DE10156804B4 Optische Meßvorrichtung für Teststreifen An optical measuring device for test strips |
| 03/17/2011 | CA2774173A1 Micro-rna, autoantibody and protein markers for diagnosis of neuronal injury |
| 03/17/2011 | CA2773824A1 Methods for diagnosis and intervention of hepatic disorders |
| 03/17/2011 | CA2773662A1 Method to identify a patient with an increased likelihood of responding to an anti-cancer agent |
| 03/17/2011 | CA2773652A1 Anti-fouling submersible liquid sensor and method |
| 03/17/2011 | CA2773614A1 Method of treating cancer by inhibiting trim59 expression or activity |
| 03/17/2011 | CA2773429A1 Biomarkers for schizophrenia or other psychotic disorders |
| 03/17/2011 | CA2773424A1 Hypoallergenic hybrid polypeptides for the treatment of allergy |
| 03/17/2011 | CA2773236A1 S. aureus allergen |
| 03/17/2011 | CA2773218A1 Use of vap-1 inhibitors for treating fibrotic conditions |
| 03/17/2011 | CA2772738A1 Glucose measurement method and system |
| 03/17/2011 | CA2772506A1 Methods and apparatus for characterization of petroleum fluid employing analysis of high molecular weight components |
| 03/17/2011 | CA2771830A1 Drug detection in exhaled breath |
| 03/17/2011 | CA2771771A1 Porcine torque teno virus vaccines and diagnosis |
| 03/17/2011 | CA2771706A1 Galectin-3 and cardiac resynchronization therapy |
| 03/17/2011 | CA2770555A1 Spontaneously contracting fish cell aggregates, use thereof and method for the production thereof |
| 03/16/2011 | EP2295988A2 Multiplexed molecular analysis apparatus and its fabrication method |
| 03/16/2011 | EP2295980A1 Molecules and methods using same for measuring non-transferrin bound iron |
| 03/16/2011 | EP2295979A2 Protein detection reagents and methods with dyes and dextrins |
| 03/16/2011 | EP2295978A2 Early pregnancy diagnosis using PAGs(Pregnancy-associated Glycoproteins) |
| 03/16/2011 | EP2295977A1 Novel tumor markers |
| 03/16/2011 | EP2295976A1 Markers for colorectal cancer |
| 03/16/2011 | EP2295975A1 Determining the expression status of human epidermal growth factor receptor 2 (HER2) in biological samples |
| 03/16/2011 | EP2295974A1 Compositions and methods for the detection of HIV-1/HIV-2 infection |
| 03/16/2011 | EP2295973A1 Compositions and methods for the detection of HIV-1/HIV-2 infection. |
| 03/16/2011 | EP2295972A1 S. aureus allergen |
| 03/16/2011 | EP2295971A2 Conjugate probes and optical detection of analytes |
| 03/16/2011 | EP2295970A1 Immunoassay analyzer and immunoassay method |
| 03/16/2011 | EP2295969A1 Method for enhancing sensitivity or method for avoiding influence of hemoglobin in immunological measurement |
| 03/16/2011 | EP2295968A2 Pyrogenicity test for use with automated immunoassay systems |
| 03/16/2011 | EP2295967A1 IgA NEPHROPATHY DETECTION METHOD AND DETECTION KIT |
| 03/16/2011 | EP2295966A1 IgA NEPHROPATHY DETECTION METHOD AND DETECTION KIT |
| 03/16/2011 | EP2295964A1 Irrigation solution |
| 03/16/2011 | EP2295963A1 Method and apparatus for determining the knot-to-volume ratio of wooden planks |
| 03/16/2011 | EP2295962A1 Method for preparation of sugar chain sample, sugar chain sample, and method for analysis of sugar chain |
| 03/16/2011 | EP2295954A1 Surface-enhanced spectroscopy-active composite nanoparticles |
| 03/16/2011 | EP2295949A1 Testing method for bolts |
| 03/16/2011 | EP2295606A1 Expression analysis of KIAA nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 03/16/2011 | EP2295603A1 Method and devices for multiplexing amplification reactions |
| 03/16/2011 | EP2295602A1 Method of diagnosing esophageal cancer |
| 03/16/2011 | EP2295600A1 Method and test strip for detecting sensitivity to isoniazid in mycobacterium tuberculosis |
| 03/16/2011 | EP2295599A1 Method for detection of idiopathic interstitial pneumonia |
| 03/16/2011 | EP2295577A2 Human cytokine as ligand of the z-alpha receptor and uses thereof |
| 03/16/2011 | EP2295574A1 Human orphan G protein-coupled receptors |
| 03/16/2011 | EP2295573A1 Human orphan G protein-coupled receptors |
| 03/16/2011 | EP2295572A1 Human orphan G protein-coupled receptors |
| 03/16/2011 | EP2295564A1 Composition and method for determination of esophageal cancer |
| 03/16/2011 | EP2295532A1 High-throughput cell-based assays fabricated with integrated silicon and cell culture technologies |
| 03/16/2011 | EP2295528A1 Methods for evaluating improved emissions catalyst durability |
| 03/16/2011 | EP2295475A1 Polymer precursors of radiolabeled compounds, and methods of making and using the same |
| 03/16/2011 | EP2295473A1 Swellable particles |
| 03/16/2011 | EP2295472A1 Swellable particles |
| 03/16/2011 | EP2295471A1 Swellable particles |
| 03/16/2011 | EP2295468A1 Anti-CD20 antibodies and fusion proteins thereof and methods of use |
| 03/16/2011 | EP2295467A1 Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof |
| 03/16/2011 | EP2295464A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 03/16/2011 | EP2295463A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 03/16/2011 | EP2295462A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 03/16/2011 | EP2295461A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 03/16/2011 | EP2295460A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 03/16/2011 | EP2295459A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 03/16/2011 | EP2295458A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 03/16/2011 | EP2295457A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 03/16/2011 | EP2295454A1 SLO2, a novel potassium channel protein from human brain |
| 03/16/2011 | EP2295447A1 GIPs, a family of polypeptides with transcription factor activity that interact with Goodpasture antigen binding protein |
| 03/16/2011 | EP2295446A1 Generation of artificial binding proteins on the basis of ubiquitin-proteins |
| 03/16/2011 | EP2295081A1 Antibodies to OPGL |
| 03/16/2011 | EP2295076A1 Hypoallergenic hybrid polypeptides for the treatment of allergy |
| 03/16/2011 | EP2295074A1 Anti-neovasculature preparations for treating cancer |
| 03/16/2011 | EP2295069A1 Treatment of neurological disorders with haematopoietic growth factors |
| 03/16/2011 | EP2295064A1 Monoclonal antibody therapy for pancreas cancer |
| 03/16/2011 | EP2295060A2 Stabilization of hypoxia inducible factor (HIF) alpha |
| 03/16/2011 | EP2295059A2 Stabilization of hypoxia inducible factor (HIF) alpha |
| 03/16/2011 | EP2294428A1 A polymer adapted to release bioactive agents in vivo, pharmaceutical composition and method of preparation thereof |
| 03/16/2011 | EP2294427A1 Assay reader, device and method for measuring hcg |
| 03/16/2011 | EP2294426A1 Method for risk reduction in glycemic control |
| 03/16/2011 | EP2294425A2 Biomarkers for myocardial ischemia |
| 03/16/2011 | EP2294424A1 L-fabp, natriuretic peptides and cardiac troponin in individuals in need for a cardiac therapy |
| 03/16/2011 | EP2294423A1 Multimarker panel for the differentiation of dilated cardiomyopathy and as basis for a differential therapy and its result |
| 03/16/2011 | EP2294422A2 Molecular markers for autism |
| 03/16/2011 | EP2294421A1 Protein disulfide isomerase assay method for the in vitro diagnosis of colorectal cancer |
| 03/16/2011 | EP2294420A2 Survival predictor for diffuse large b cell lymphoma |
| 03/16/2011 | EP2294419A1 Compostions and methods for treating corneal inflammation |
| 03/16/2011 | EP2294418A2 Cleavable catalytic binding and detection system |
| 03/16/2011 | EP2294417A2 Compositions and methods relating to detection of soluble e-cadherin in neurodegenerative disease |
| 03/16/2011 | EP2294416A1 Inhibition of the nt-3:trkc bound and its application to the treatment of cancer such as neuroblastoma |
| 03/16/2011 | EP2294415A1 Analyte detection by microneedle patch with analyte selective reagents. |